These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 30141909)
1. Structural Changes and Aggregation Mechanisms of Two Different Dimers of an IgG2 Monoclonal Antibody. Zhang J; Woods C; He F; Han M; Treuheit MJ; Volkin DB Biochemistry; 2018 Sep; 57(37):5466-5479. PubMed ID: 30141909 [TBL] [Abstract][Full Text] [Related]
2. The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensity. Knight MJ; Floret L; Patel N; O'Hara J; Rodriguez E MAbs; 2022; 14(1):2127172. PubMed ID: 36198003 [TBL] [Abstract][Full Text] [Related]
3. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis. Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480 [TBL] [Abstract][Full Text] [Related]
4. Conformational difference in human IgG2 disulfide isoforms revealed by hydrogen/deuterium exchange mass spectrometry. Zhang A; Fang J; Chou RY; Bondarenko PV; Zhang Z Biochemistry; 2015 Mar; 54(10):1956-62. PubMed ID: 25730439 [TBL] [Abstract][Full Text] [Related]
5. Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements. Iacob RE; Bou-Assaf GM; Makowski L; Engen JR; Berkowitz SA; Houde D J Pharm Sci; 2013 Dec; 102(12):4315-29. PubMed ID: 24136070 [TBL] [Abstract][Full Text] [Related]
6. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life. Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD MAbs; 2015; 7(1):84-95. PubMed ID: 25524268 [TBL] [Abstract][Full Text] [Related]
7. Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs. Plath F; Ringler P; Graff-Meyer A; Stahlberg H; Lauer ME; Rufer AC; Graewert MA; Svergun D; Gellermann G; Finkler C; Stracke JO; Koulov A; Schnaible V MAbs; 2016 Jul; 8(5):928-40. PubMed ID: 27031922 [TBL] [Abstract][Full Text] [Related]
8. Distinctive Low-Resolution Structural Features of Dimers of Antibody-Drug Conjugates and Parent Antibody Determined by Small-Angle X-ray Scattering. Law-Hine D; Rudiuk S; Bonestebe A; Ienco R; Huille S; Tribet C Mol Pharm; 2019 Dec; 16(12):4902-4912. PubMed ID: 31618040 [TBL] [Abstract][Full Text] [Related]
9. Elucidation of two major aggregation pathways in an IgG2 antibody. Van Buren N; Rehder D; Gadgil H; Matsumura M; Jacob J J Pharm Sci; 2009 Sep; 98(9):3013-30. PubMed ID: 18680168 [TBL] [Abstract][Full Text] [Related]
10. Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition. Hari SB; Lau H; Razinkov VI; Chen S; Latypov RF Biochemistry; 2010 Nov; 49(43):9328-38. PubMed ID: 20843079 [TBL] [Abstract][Full Text] [Related]
11. Isotype dependent on-column non-reversible aggregation of monoclonal antibodies. Farys M; Gibson D; Lewis AP; Lewis W; Kucia-Tran R Biotechnol Bioeng; 2018 May; 115(5):1279-1287. PubMed ID: 29315494 [TBL] [Abstract][Full Text] [Related]
12. Remediating agitation-induced antibody aggregation by eradicating exposed hydrophobic motifs. Clark RH; Latypov RF; De Imus C; Carter J; Wilson Z; Manchulenko K; Brown ME; Ketchem RR MAbs; 2014; 6(6):1540-50. PubMed ID: 25484048 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Hydrogen Exchange Mass Spectrometry as a Stability-Indicating Method for Formulation Excipient Screening for an IgG4 Monoclonal Antibody. Toth RT; Pace SE; Mills BJ; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB J Pharm Sci; 2018 Apr; 107(4):1009-1019. PubMed ID: 29269271 [TBL] [Abstract][Full Text] [Related]
14. Structure and function of purified monoclonal antibody dimers induced by different stress conditions. Paul R; Graff-Meyer A; Stahlberg H; Lauer ME; Rufer AC; Beck H; Briguet A; Schnaible V; Buckel T; Boeckle S Pharm Res; 2012 Aug; 29(8):2047-59. PubMed ID: 22477068 [TBL] [Abstract][Full Text] [Related]
15. Conformational implications of an inversed pH-dependent antibody aggregation. Perico N; Purtell J; Dillon TM; Ricci MS J Pharm Sci; 2009 Sep; 98(9):3031-42. PubMed ID: 18803243 [TBL] [Abstract][Full Text] [Related]
16. Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies. Thakkar SV; Sahni N; Joshi SB; Kerwin BA; He F; Volkin DB; Middaugh CR Protein Sci; 2013 Oct; 22(10):1295-305. PubMed ID: 23893936 [TBL] [Abstract][Full Text] [Related]
17. Intermolecular interactions and conformation of antibody dimers present in IgG1 biopharmaceuticals. Iwura T; Fukuda J; Yamazaki K; Kanamaru S; Arisaka F J Biochem; 2014 Jan; 155(1):63-71. PubMed ID: 24155259 [TBL] [Abstract][Full Text] [Related]
18. Assessment of disulfide and hinge modifications in monoclonal antibodies. Moritz B; Stracke JO Electrophoresis; 2017 Mar; 38(6):769-785. PubMed ID: 27982442 [TBL] [Abstract][Full Text] [Related]
19. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions. Yageta S; Lauer TM; Trout BL; Honda S Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775 [TBL] [Abstract][Full Text] [Related]
20. Assessment of naturally occurring covalent and total dimer levels in human IgG1 and IgG2. Yang J; Goetze AM; Flynn GC Mol Immunol; 2014 Mar; 58(1):108-15. PubMed ID: 24321397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]